Cargando…

重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342562/
https://www.ncbi.nlm.nih.gov/pubmed/29562453
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.02.016
_version_ 1783555523671490560
collection PubMed
description
format Online
Article
Text
id pubmed-7342562
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73425622020-07-16 重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2018-02 /pmc/articles/PMC7342562/ /pubmed/29562453 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.02.016 Text en 2018年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察
title 重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察
title_full 重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察
title_fullStr 重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察
title_full_unstemmed 重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察
title_short 重组人凝血因子Ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察
title_sort 重组人凝血因子ⅶa联合免疫抑制剂治疗异基因造血干细胞移植后肠道急性移植物抗宿主病并发出血疗效观察
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342562/
https://www.ncbi.nlm.nih.gov/pubmed/29562453
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.02.016
work_keys_str_mv AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá
AT zhòngzǔrénníngxuèyīnziviialiánhémiǎnyìyìzhìjìzhìliáoyìjīyīnzàoxuègànxìbāoyízhíhòuchángdàojíxìngyízhíwùkàngsùzhǔbìngbìngfāchūxuèliáoxiàoguānchá